Adherence to guideline-recommended therapies among patients with diverse manifestations of vascular disease

Current guidelines recommend aspirin, statins, angiotensin-converting enzyme inhibitors (ACEIs), and smoking abstinence for all patients with vascular disease. There is little data on the variation in adherence to guideline-recommended therapies among patients with different clinical manifestations...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Vascular health and risk management Ročník 11; číslo default; s. 185 - 193
Hlavní autoři:	Chen, Debbie, Armstrong, Ehrin, Singh, Gagan, Amsterdam, Ezra, Laird, John
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	New Zealand Dove Medical Press Limited 01.01.2015 Taylor & Francis Ltd Dove Press Dove Medical Press
Témata:	Aged Angiotensin-Converting Enzyme Inhibitors - therapeutic use Aspirin Aspirin - therapeutic use Blood circulation disorders California Cardiology Cardiovascular disease Care and treatment Carotid arteries Cholesterol Chronic obstructive pulmonary disease Collaboration Coronary vessels Data collection Diabetes Enzymes Evaluation Female Forecasts and trends Guideline Adherence Health risk assessment Heart attacks Heart failure Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Hypertension Ischemia Male Medical imaging Medical prognosis Middle Aged Mortality Original Research Patient compliance Patients peripheral arterial disease Peripheral Arterial Disease - complications Peripheral Arterial Disease - diagnosis Peripheral Arterial Disease - mortality Peripheral Arterial Disease - therapy Platelet Aggregation Inhibitors - therapeutic use Practice guidelines (Medicine) Practice Guidelines as Topic Practice Patterns, Physicians' - standards Registries Retrospective Studies Risk Factors secondary prevention Secondary Prevention - methods Smoking - adverse effects Smoking - mortality Smoking Cessation Smoking Prevention statin medications Statins Stroke United States > US California statin medications peripheral arterial disease secondary prevention
ISSN:	1178-2048, 1176-6344, 1178-2048
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!